Novus Scientific presents initial results of the First-in-Man study for TIGR® Matrix Surgical Mesh – The world’s 1st long-term resorbable synthetic mesh

Dokument -

Novus Scientific presents initial results of the First-in-Man study for TIGR® Matrix Surgical Mesh – The world’s 1st long-term resorbable synthetic mesh

Novus Scientific Pte. Ltd today announced the presentation of initial results of the First-in-Man study for TIGR® Matrix Surgical Mesh. The study results were presented today at the American Hernia Society Meeting in Orlando, Florida by Dr. Fernando Ruiz-Jasbon, Consultant Surgeon at Kungsbacka Hospital / Gothenburg University, Sweden.
  • Licens: All rights reserved
    Innehållet får bara användas av Mynewsdesk. Det är alltså inte tillåtet för någon annan att ladda ner, kopiera, sprida eller på annat sätt använda Innehållet (annat än för privat bruk i den mån det följer av lag).
  • Filformat: .pdf

Kontakter

Jan Hermansson

Presskontakt Global Produktchef Försäljning och Distributörsstöd

Relaterat innehåll

Novus Scientific presents initial results of the First-in-Man study for TIGR® Matrix Surgical Mesh – The world’s 1st long-term resorbable synthetic mesh

Novus Scientific Pte. Ltd today announced the presentation of initial results of the First-in-Man study for TIGR® Matrix Surgical Mesh. The study results were presented today at the American Hernia Society Meeting in Orlando, Florida by Dr. Fernando Ruiz-Jasbon, Consultant Surgeon at Kungsbacka Hospital / Gothenburg University, Sweden.